Results 221 to 230 of about 644,115 (313)

In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra. [PDF]

Res Pract Thromb Haemost, 2022
Brinkman HJM, Zuurveld M, Meijers JCM.
europepmc   +1 more source

The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. [PDF]

Sci Rep
Hamada S, Muramoto K, Akaike K, Okabayashi H, Masunaga A, Tomita Y, Ichiyasu H, Sakagami T.   +7 more
europepmc   +1 more source

Peripheral Neuropathy During Concomitant Administration of Proteasome Inhibitors and Factor Xa Inhibitors: Identifying the Likelihood of Drug-Drug Interactions. [PDF]

Front Pharmacol, 2022
Meng L, Huang J, Qiu F, Shan X, Chen L, Sun S, Wang Y, Yang J.   +7 more
europepmc   +1 more source

Orally Administered Factor Xa Inhibitor, Rivaroxaban

, 2008
Ricardo J. Komotar, Robert M. Starke, E. Sander Connolly   +2 more
openalex   +1 more source

Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial. [PDF]

Res Pract Thromb Haemost
Hamulyák EN, Wiegers HMG, Hutten BA, de Lange ME, Timmermans A, Westerweel PE, Nijziel MR, Klok FA, Hovens MM, Kamphuisen PW, Büller HR, Middeldorp S, Scheres LJJ.   +12 more
europepmc   +1 more source

A new Factor Xa inhibitor from Amblyomma cajennense with a unique domain composition

, 2009
Isabel de Fátima Correia Batista, Oscar Henrique Pereira Ramos, J.S. Ventura, Inácio L.M. Junqueira-de-Azevedo, Paulo Lee Ho, A.M. Chudzinski-Tavassi   +5 more
openalex   +1 more source

Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches [PDF]

, 1991
A Billing, A Billing, B Blauhut, C Gippner-Steppert, D Inthorn, D Nast-Kolb, H Hoffmann, H Vinazzer, I Assfalg-Machleidt, I Schraufstatter, JI Weitz, K-H Duswald, M Jochum, M Jochum, M Jochum, M Jochum, M Jochum, M Jochum, M Jochum, M Jochum, M Siebeck, M Siebeck, M Spannagl, MD Wewers, RE Jordan, S Idell, S Neumann, TE Emerson, U Obertacke, YT Wachtfogel, YT Wachtfogel   +30 more
core   +1 more source

Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation

Therapeutic Advances in Cardiovascular Disease, 2016
D. McCarty, A. Robinson
semanticscholar   +1 more source

Factor Xa inhibitors vs. warfarin in patients with Hughes syndrome: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Mohtashim A, Azhar A, Mazhar S, Devi D, Danial M, Patel D, Khan O, Andani A, Khan MM, Samad S, Qureshi A, Ali H, Ejaz U, Jawad S.   +13 more
europepmc   +1 more source

Inhibition of Coagulation Activation and Inflammation by a Novel Factor Xa Inhibitor Synthesized from the Earthworm Eisenia andrei

, 2009
Seong Soo Joo, Taejoon Won, Jong Sung Kim, Yeong Min Yoo, Eun Sik Tak, So‐Young Park, Hee Yong Park, Kwang Woo Hwang, Soon Cheol Park, Do Ik Lee   +9 more
openalex   +2 more sources